Geron Corporation (GERN)
NASDAQ: GERN · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Sep 4, 2025, 4:00 PM
1.370
-0.010 (-0.72%)
Pre-market: Sep 5, 2025, 5:22 AM EDT
Geron Revenue
Geron had revenue of $49.04M in the quarter ending June 30, 2025, with 5,459.64% growth. This brings the company's revenue in the last twelve months to $164.45M, up 11,877.20% year-over-year. In the year 2024, Geron had annual revenue of $76.99M with 32,386.92% growth.
Revenue (ttm)
$164.45M
Revenue Growth
+11,877.20%
P/S Ratio
5.58
Revenue / Employee
$718,109
Employees
229
Market Cap
880.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 76.99M | 76.76M | 32,386.92% |
| Dec 31, 2023 | 237.00K | -359.00K | -60.23% |
| Dec 31, 2022 | 596.00K | -797.00K | -57.21% |
| Dec 31, 2021 | 1.39M | 1.14M | 450.59% |
| Dec 31, 2020 | 253.00K | -207.00K | -45.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
GERN News
- 8 days ago - Geron to Participate in the 2025 Wells Fargo Healthcare Conference - Business Wire
- 17 days ago - Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 21 days ago - Geron Corporation Investors: Company Investigated by the Portnoy Law Firm - GlobeNewsWire
- 27 days ago - Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 27 days ago - Geron: I Think We've Seen This Movie Before - Seeking Alpha
- 4 weeks ago - Geron Corporation (GERN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Business Wire
- 4 weeks ago - Geron Appoints Harout Semerjian as President and Chief Executive Officer - Business Wire